(i) A covered model poses an unreasonable risk of causing or enabling a critical harm.
(ii) Covered model derivatives pose an unreasonable risk of causing or enabling a critical harm.
(D) Describes in detail how the testing procedure assesses the risks associated with post-training modifications.
(E) Describes in detail how the testing procedure addresses the possibility that a covered model or covered model derivative can be used to make post-training modifications or create another covered model in a manner that may cause or materially enable a critical harm.
(F) Describes in detail how the developer will fulfill their obligations under this chapter.
You are viewing a single comment's thread from: